Lazard Asset Management LLC Acquires New Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Lazard Asset Management LLC acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 30,648 shares of the company's stock, valued at approximately $1,034,000.

Other hedge funds also recently bought and sold shares of the company. Operose Advisors LLC purchased a new position in Tempus AI in the 4th quarter worth approximately $25,000. Farther Finance Advisors LLC purchased a new position in Tempus AI in the 4th quarter worth approximately $34,000. Prestige Wealth Management Group LLC grew its stake in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after buying an additional 965 shares in the last quarter. NewEdge Advisors LLC purchased a new position in Tempus AI in the 4th quarter worth approximately $49,000. Finally, First Horizon Advisors Inc. grew its stake in Tempus AI by 207.9% in the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock worth $55,000 after buying an additional 1,108 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on TEM shares. Piper Sandler boosted their price objective on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. JPMorgan Chase & Co. lowered shares of Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price objective for the stock from $50.00 to $55.00 in a report on Tuesday, February 25th. Morgan Stanley boosted their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 price objective for the company. Finally, Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $62.75.

Tempus AI Trading Down 2.7%

NASDAQ:TEM opened at $63.74 on Tuesday. The company has a fifty day moving average of $50.41 and a 200 day moving average of $51.89. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a market capitalization of $10.98 billion and a P/E ratio of -8.17.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. The company's quarterly revenue was up 75.4% on a year-over-year basis. On average, research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Insiders Place Their Bets

In other Tempus AI news, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the transaction, the director now directly owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Ryan M. Bartolucci sold 818 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $81.87, for a total transaction of $66,969.66. Following the completion of the transaction, the chief accounting officer now owns 46,182 shares of the company's stock, valued at $3,780,920.34. This trade represents a 1.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,971,869 shares of company stock worth $230,107,754. 27.60% of the stock is currently owned by corporate insiders.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.